November 20, 2023 11:09 AM EST
News Briefing

Chiesi’s new li­cens­ing deal with Hais­co; Ox­u­ri­on to file for bank­rupt­cy; Hong Kong CD­MO rais­es $210M

Jaimy Lee

Deputy Editor

Chiesi, Hais­co to de­vel­op res­pi­ra­to­ry treat­ment out­side of Chi­na: The com­pa­nies said Mon­day that they plan to work to­geth­er to de­vel­op …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

GSK leaves biotech trade group BIO

Biotech in­dus­try wor­ries over po­ten­tial for RFK Jr. al­ly as FDA pick

Ei­sai slash­es Leqem­bi sales fore­cast by al­most $100M

Am­gen and As­traZeneca share pos­i­tive re­sults in chron­ic rhi­nos­i­nusi­tis

Benev­o­len­tAI’s co-founder is back. Here’s how he plans a turn­around at the AI com­pa­ny dur­ing a ‘piv­otal time’

sponsored

Gene ther­a­pies don’t have to cost $4 mil­lion: New pro­duc­tion plat­forms re­duce de­vel­op­ment costs and risks

A service from the Financial Times